Insight Molecular Diagnostics (IMDX) Inventory (2024 - 2026)

Insight Molecular Diagnostics has disclosed Inventory across 3 years of filings, most recently posting $382000.0 for Q1 2026.

• Inventory for Q1 2026 came in at $382000.0, down 16.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $382000.0 (down 16.78% YoY), and the FY2025 annual result was $446000.0, up 8.78% from the prior year.
• Inventory came in at $382000.0 for Q1 2026 at Insight Molecular Diagnostics, down from $446000.0 in the prior quarter.
• In the past five years, Inventory ranged from a high of $693000.0 in Q2 2025 to a low of $232000.0 in Q3 2024.
• The 3-year median for Inventory is $446000.0 (2025), against an average of $441857.1.
• Across the five-year window, Inventory jumped 103.02% in 2025 and dropped 16.78% in 2026, its largest moves.
• Insight Molecular Diagnostics' Inventory stood at $410000.0 in 2024, then increased by 8.78% to $446000.0 in 2025, then decreased by 14.35% to $382000.0 in 2026.
• The last three Inventory figures came in at $382000.0 (Q1 2026), $446000.0 (Q4 2025), and $471000.0 (Q3 2025), per Business Quant data.